Oxurion NV (EBR:OXUR)
Belgium
· Delayed Price · Currency is EUR 0.0560
+0.0010 (1.82%)
May 28, 2025, 3:50 PM CET
Oxurion NV Revenue
In the year 2024, Oxurion NV had annual revenue of 3.00K EUR, down -98.86%. Oxurion NV had revenue of 2.00K in the half year ending December 31, 2024, a decrease of -99.40%.
Revenue
3.00K
Revenue Growth
-98.86%
P/S Ratio
114.91
Revenue / Employee
272.73
Employees
11
Market Cap
344.74K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00K | -260.00K | -98.86% |
| Dec 31, 2023 | 263.00K | -332.00K | -55.80% |
| Dec 31, 2022 | 595.00K | -533.00K | -47.25% |
| Dec 31, 2021 | 1.13M | -950.00K | -45.72% |
| Dec 31, 2020 | 2.08M | -1.87M | -47.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.45B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 498.16M |
| Nyxoah | 4.36M |
| Onward Medical | 1.74M |
| Hyloris Pharmaceuticals | 9.76M |